Cite
In Vitro Predictive Dissolution Test Should Be Developed and Recommended as a Bioequivalence Standard for the Immediate-Release Solid Oral Dosage Forms of the Highly Variable Mycophenolate Mofetil
MLA
Kai Wang, et al. “In Vitro Predictive Dissolution Test Should Be Developed and Recommended as a Bioequivalence Standard for the Immediate-Release Solid Oral Dosage Forms of the Highly Variable Mycophenolate Mofetil.” Molecular Pharmaceutics, vol. 19, May 2022, pp. 2048–60. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....aa424c92f7ea7e32186960b60a115d6d&authtype=sso&custid=ns315887.
APA
Kai Wang, Yangbing Li, Bing Chen, Hao Chen, David E. Smith, Duxin Sun, Meihua R. Feng, & Gordon L. Amidon. (2022). In Vitro Predictive Dissolution Test Should Be Developed and Recommended as a Bioequivalence Standard for the Immediate-Release Solid Oral Dosage Forms of the Highly Variable Mycophenolate Mofetil. Molecular Pharmaceutics, 19, 2048–2060.
Chicago
Kai Wang, Yangbing Li, Bing Chen, Hao Chen, David E. Smith, Duxin Sun, Meihua R. Feng, and Gordon L. Amidon. 2022. “In Vitro Predictive Dissolution Test Should Be Developed and Recommended as a Bioequivalence Standard for the Immediate-Release Solid Oral Dosage Forms of the Highly Variable Mycophenolate Mofetil.” Molecular Pharmaceutics 19 (May): 2048–60. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....aa424c92f7ea7e32186960b60a115d6d&authtype=sso&custid=ns315887.